by Peter Ciszewski | Aug 24, 2021
Avanish Vellanki, Cofounder and CEO at Rain Therapeutics, discusses the recent initiation of the phase 3 MANTRA trial of milademetan versus trabectedin in patients with dedifferentiated liposarcoma. Liposarcoma is a rare cancer originating from fat cells...
by Peter Ciszewski | Aug 23, 2021
Roman Grosiberg, MD, Medical Oncologist and Director of the Sarcoma Program at Rutgers Cancer Institute of New Jersey/RWJBarnabas Health, gives an overview of sarcomas. Sarcomas are rare cancers that develop in the bones and soft tissues, including fat,...
by Peter Ciszewski | Aug 23, 2021
Michael J. Thorpy, MD, ChB, Director of the Sleep-Wake Disorders Center at the Montefiore Medical Center, discusses what physicians ought to know about narcolepsy that they typically do not. Narcolepsy is a rare neurological disorder characterized by excessive...
by Peter Ciszewski | Aug 19, 2021
Gary Joseph Lelli, MD, of the Department of Ophthalmology at Weill Cornell Medicine, discusses the importance of finding a specialist for thyroid eye disease (TED) and how to find one. TED is a rare autoimmune disease causing permanent facial disfigurement...
by Peter Ciszewski | Aug 18, 2021
Michael J. Thorpy, MD, ChB, Director of the Sleep-Wake Disorders Center at the Montefiore Medical Center, discusses the post hoc analyses of data from the REST-ON clinical trial of FT218, an investigational treatment for narcolepsy. Narcolepsy is a rare...
